IFNG and congenital rubella syndrome: Although reports have shown that the serum IFNG level in patients with CRS associated with COVID-19 is significantly lower than that in healthy controls [41], the therapeutic effect of IFNG injection on patients with severe COVID-19 remains controversial [40].